New Millennium Group’s Innoviva INVA Stock Holding History

New Millennium Group’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	-$1K	–	381
2022 Q2	$1K	Buy	+100	New	+$1.64K	﹤0.01%	334

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Millennium Group's INVA Position: Q3 2022 in Review

New Millennium Group sold out of Innoviva (INVA) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

New Millennium Group first reported a position in INVA in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 214 funds tracked by Wall St. Rank hold INVA as of Q3 2022.

New Millennium Group reported no remaining Innoviva position as of Q3 2022 after selling out during the quarter.
New Millennium Group sold 100 Innoviva shares in Q3 2022, an estimated $1K.
New Millennium Group first reported a position in Innoviva in Q2 2022 and held it in 1 quarter.
New Millennium Group's Innoviva position peaked at $1K in Q2 2022.
214 funds tracked by Wall St. Rank held Innoviva as of Q3 2022.

Based on New Millennium Group's 13F filing for Q3 2022, filed 14 Nov 2022.